MASH cirrhosis has traditionally been considered irreversible. However, new data from investigators at Cleveland Clinic, presented at Digestive Disease Week…
Browsing: Clinical Updates
An experimental drug called daraxonrasib is generating major excitement in pancreatic cancer after early trials showed it could significantly extend…
The updated 13-year NordICC data showed that colonoscopy screening reduced colorectal cancer incidence by about 30%, strengthening the benefit seen…
Inflammatory bowel disease (IBD) presents unique challenges for older adults, particularly those in Medicare Advantage (MA) plans. In this population,…
An investigational procedure—duodenal mucosal resurfacing (DMR)—is emerging as a potential solution to one of the biggest challenges in obesity care:…
A large population-based study shows a stark reality: colorectal cancer (CRC) risk isn’t just about screening—it’s about completion of the…
Creative approaches to salvage patients with poor bowel preparations and appropriate application of computer-aided detection, narrow band imaging, and other…
Researchers led by Animesh Acharjee at the University of Birmingham have identified overlapping microbial and metabolite patterns in stool samples…
A prospective study on virtual multidisciplinary GI care is challenging the assumption that complex gastrointestinal conditions require fragmented, in-person management.…
A new validation study of the American Society for Gastrointestinal Endoscopy (ASGE) complexity grading system confirms something clinicians intuitively know:…